SYN-Tech Chem & Pharm Co Ltd (TWO:1777) — Stock Price
SYN-Tech Chem & Pharm Co Ltd (TWO:1777) is currently trading at NT$75.00 TWD, up 0.27% today. Over the past 52 weeks, shares have ranged between NT$70.30 and NT$79.30. This page tracks SYN-Tech Chem & Pharm Co Ltd's live share price on the TWO exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see SYN-Tech Chem & Pharm Co Ltd stock valuation.
SYN-Tech Chem & Pharm Co Ltd (1777) Stock Price Chart — Daily History & Trading Volume
The chart below tracks SYN-Tech Chem & Pharm Co Ltd's daily closing share price and trading volume on the TWO exchange over the past year, giving a clear view of recent price momentum and liquidity.
SYN-Tech Chem & Pharm Co Ltd Income Statement — Revenue, Profit & Earnings by Year
SYN-Tech Chem & Pharm Co Ltd's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | NT$1.30 Billion | NT$1.26 Billion | NT$1.11 Billion | NT$986.30 Million | NT$893.23 Million |
| Cost of Revenue | NT$849.88 Million | NT$770.72 Million | NT$712.14 Million | NT$625.32 Million | NT$609.22 Million |
| Gross Profit | NT$450.36 Million | NT$486.94 Million | NT$402.55 Million | NT$360.98 Million | NT$284.01 Million |
| Research & Development | NT$38.87 Million | NT$42.51 Million | NT$37.91 Million | NT$36.83 Million | NT$36.48 Million |
| SG&A | NT$91.63 Million | NT$93.45 Million | NT$46.51 Million | NT$44.66 Million | NT$42.16 Million |
| Total Operating Expenses | NT$980.38 Million | NT$906.68 Million | NT$120.69 Million | NT$122.75 Million | NT$115.43 Million |
| Operating Income | NT$319.86 Million | NT$350.98 Million | NT$281.85 Million | NT$238.23 Million | NT$168.59 Million |
| EBITDA | — | — | NT$393.61 Million | NT$319.08 Million | NT$240.04 Million |
| EBIT | — | — | NT$281.85 Million | NT$238.23 Million | NT$168.59 Million |
| Interest Expense | NT$1.00 Million | NT$2.14 Million | NT$5.74 Million | NT$5.92 Million | NT$3.39 Million |
| Income Before Tax | NT$333.92 Million | NT$488.24 Million | NT$313.06 Million | NT$366.82 Million | NT$200.96 Million |
| Income Tax Expense | — | — | NT$62.76 Million | NT$59.95 Million | NT$23.07 Million |
| Net Income | NT$261.61 Million | NT$393.28 Million | NT$251.01 Million | NT$295.29 Million | NT$177.16 Million |
SYN-Tech Chem & Pharm Co Ltd Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes SYN-Tech Chem & Pharm Co Ltd's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | NT$2.96 Billion | NT$2.85 Billion | NT$2.90 Billion | NT$2.78 Billion | NT$2.90 Billion |
| Total Current Assets | NT$1.53 Billion | NT$1.33 Billion | NT$1.42 Billion | NT$1.59 Billion | NT$2.14 Billion |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | NT$119.16 Million | NT$259.09 Million |
| Net Receivables | NT$113.86 Million | NT$140.14 Million | NT$282.83 Million | NT$265.92 Million | NT$313.13 Million |
| Inventory | NT$340.46 Million | NT$503.31 Million | NT$459.98 Million | NT$353.63 Million | NT$322.12 Million |
| Property, Plant & Equipment | — | — | — | — | NT$619.98 Million |
| Goodwill | — | — | — | — | — |
| Total Liabilities | NT$369.57 Million | NT$291.65 Million | NT$583.48 Million | NT$580.13 Million | NT$911.71 Million |
| Total Current Liabilities | NT$304.49 Million | NT$219.47 Million | NT$507.01 Million | NT$503.73 Million | NT$839.98 Million |
| Long-term Debt | — | — | — | — | — |
| Net Debt | — | — | NT$-264.17 Million | NT$-416.97 Million | NT$-464.73 Million |
| Total Stockholder Equity | NT$2.59 Billion | NT$2.56 Billion | NT$2.32 Billion | NT$2.20 Billion | NT$1.98 Billion |
| Retained Earnings | NT$887.33 Million | NT$896.50 Million | NT$678.88 Million | NT$584.77 Million | NT$436.53 Million |
SYN-Tech Chem & Pharm Co Ltd Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how SYN-Tech Chem & Pharm Co Ltd generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | NT$559.49 Million | NT$622.61 Million | NT$262.29 Million | NT$438.81 Million | NT$156.98 Million |
| Capital Expenditures | NT$58.30 Million | NT$213.75 Million | NT$437.34 Million | NT$477.40 Million | NT$127.22 Million |
| Free Cash Flow | NT$501.19 Million | NT$408.85 Million | NT$-175.05 Million | NT$-38.59 Million | NT$29.76 Million |
| Investing Cash Flow | — | — | — | — | NT$-354.91 Million |
| Financing Cash Flow | — | — | NT$-123.66 Million | NT$-476.17 Million | NT$840.04 Million |
| Dividends Paid | NT$-236.34 Million | NT$-156.07 Million | NT$133.78 Million | NT$86.13 Million | NT$120.24 Million |
| Stock-Based Compensation | — | — | — | NT$0.00 | NT$7.88 Million |
| Depreciation | NT$147.13 Million | NT$143.99 Million | NT$111.75 Million | NT$80.85 Million | NT$71.45 Million |
| Change in Cash | NT$391.81 Million | NT$-10.12 Million | NT$-178.04 Million | NT$-384.90 Million | NT$610.71 Million |
SYN-Tech Chem & Pharm Co Ltd Earnings History — EPS Actual vs. Analyst Estimates
Track SYN-Tech Chem & Pharm Co Ltd's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Jun 20, 2025 | — | — | — |
| Mar 07, 2024 | 0.57 | 1.45 | -60.69% |
| Nov 06, 2023 | 2.07 | 1.60 | +29.38% |
| Aug 07, 2023 | 1.51 | 1.28 | +17.97% |
| May 09, 2023 | 1.47 | 1.15 | +27.83% |
| Mar 13, 2023 | 0.52 | — | — |
| Nov 02, 2022 | 2.54 | 0.73 | +247.95% |
| Aug 02, 2022 | 1.72 | 0.59 | +191.53% |